
TY  - JOUR
TI  - Poster Session Abstracts
JO  - Psychophysiology
JA  - Psychophysiology
VL  - 53
IS  - S1
SN  - 0048-5772
UR  - https://doi.org/10.1111/psyp.12719
DO  - doi:10.1111/psyp.12719
SP  - S17
EP  - S96
PY  - 2016
ER  - 

TY  - JOUR
TI  - 22nd Annual Meeting of the Wound Healing Society. 6th Joint Meeting with the European Tissue Repair Society SAWC-Spring/WHS Joint Meeting
JO  - Wound Repair and Regeneration
JA  - Wound Repair Regen
VL  - 20
IS  - 2
SN  - 1067-1927
UR  - https://doi.org/10.1111/j.1524-475X.2012.00774.x
DO  - doi:10.1111/j.1524-475X.2012.00774.x
SP  - A12
EP  - A48
PY  - 2012
ER  - 

AU  - Bosch, Jaime
AU  - Berzigotti, Annalisa
C7  - pp. 180-208
TI  - Portal Hypertension in Cirrhosis
SN  - 9781119237549
UR  - https://doi.org/10.1002/9781119237662.ch11
DO  - doi:10.1002/9781119237662.ch11
SP  - 180-208
KW  - cirrhosis
KW  - clinical scenario
KW  - pathophysiology
KW  - portal hypertension
KW  - randomized controlled trial
KW  - therapeutic strategies
PY  - 2012
AB  - Summary Portal hypertension drives the prognosis of cirrhosis leading to the development of the complications that define decompensation. Portal hypertension due to liver disease is classified as intrahepatic portal hypertension. This chapter presents a list of causes of portal hypertension based on this classification. Understanding of the pathophysiology of portal hypertension has greatly benefited from the development of animal models of cirrhosis and prehepatic portal hypertension. The knowledge gained has allowed for a successful transition into therapeutic strategies. The chapter focuses on the evaluation and diagnosis of portal hypertension in cirrhosis. Treatment of portal hypertension is different depending on the clinical scenario. The chapter then summarizes the natural history of chronic liver disease according to data obtained from a large prospective randomized controlled trial (RCT) and a systematic review.
ER  - 

AU  - Ngiam, Michelle
AU  - Liao, Susan
AU  - Chan, Casey
AU  - Ramakrishna, S.
C7  - pp. 551-588
TI  - Cell-Based Nanocomposites and Biomolecules for Bone Tissue Engineering
SN  - 9780470193402
UR  - https://doi.org/10.1002/9780470891315.ch16
DO  - doi:10.1002/9780470891315.ch16
SP  - 551-588
KW  - cell-based nanocomposites and biomolecules - bone tissue engineering
KW  - bone grafts - healthy bone tissue is harvested from the patient
KW  - sources of stem cells - bone tissue engineering increasing osteogenic differentiation
PY  - 2012
AB  - Summary This chapter contains sections titled: Introduction Bone Grafts Types of Materials for Bone Applications Sources of Stem Cells Used for Bone Tissue Engineering to Increase Osteogenic Differentiation Current Perspective Conclusion References
ER  - 

TY  - JOUR
TI  - Abstracts of the BAUS Annual Meeting: Harrogate, UK, 21-25 June, 2004
JO  - BJU International
VL  - 93
IS  - s4
SN  - 9780470193402
UR  - https://doi.org/10.1111/j.1464-410X.2004.04853.x
DO  - doi:10.1111/j.1464-410X.2004.04853.x
SP  - 1
EP  - 116
PY  - 2004
ER  - 

TY  - JOUR
AU  - Zhao, Yan
AU  - Li, Hailiang
AU  - Bai, Wei
AU  - Liu, Jueshi
AU  - Lv, Weifu
AU  - Sahu, Sonia
AU  - Guan, Sheng
AU  - Qin, Xiao
AU  - Wang, Wenhui
AU  - Ren, Weixin
AU  - Mu, Wei
AU  - Guo, Weidong
AU  - Gu, Shanzhi
AU  - Ma, Yilong
AU  - Yin, Zhanxin
AU  - Guo, Wengang
AU  - Wang, Wenjun
AU  - Wang, Yongji
AU  - Duran, Rafael
AU  - Fan, Daiming
AU  - Zhang, Zhuoli
AU  - Han, Guohong
TI  - Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients
JO  - International Journal of Cancer
JA  - Int. J. Cancer
VL  - 139
IS  - 4
SN  - 9780470193402
UR  - https://doi.org/10.1002/ijc.30124
DO  - doi:10.1002/ijc.30124
SP  - 928
EP  - 937
KW  - hepatocellular carcinoma
KW  - transarterial chemoembolization
KW  - sorafenib
KW  - dermatologic adverse events
KW  - biomarker
PY  - 2016
AB  - The purpose of our study was to test the hypothesis that sorafenib-related dermatologic adverse events (AEs) as an early biomarker can predict the long-term outcomes following the combination therapy of transarterial chemoembolization (TACE) plus sorafenib (TACE-S). The intermediate-stage hepatocellular carcinoma patients who received either TACE-S or TACE-alone treatment were consecutively included into analysis. In the TACE-S group, patients with?≥?grade 2 dermatologic AEs within the first month of sorafenib initiation were defined as responders; whereas those with?<?grade 2 were defined as nonresponders. In the TACE-S group, the median overall survival (OS) of the responders was significantly longer than that of nonresponders (28.9 months vs. 16.8 months, respectively; p?=?0.004). Multivariate analysis demonstrated that nonresponders were significantly associated with an increased risk of death compared with responders (HR?=?1.9; 95% confidence Interval-CI: 1.3?2.7; p?=?0.001). The survival analysis showed that the median OS was 27.9 months (95% CI: 25.0?30.8) among responders treated with TACE-S vs.18.3 months (95% CI: 14.5?22.1) among those who received TACE-alone (p?=?0.046). The median time to progression was 13.1 months (95% CI: 4.4?21.8) in the TACE-S group, a duration that was significantly longer than that in the TACE-alone group [5 months (95% CI: 6.4?13.3), p?=?0.014]. This study demonstrated that sorafenib-related dermatologic AEs are clinical biomarkers to identify responders from all of the patients for TACE-S therapy. Sorafenib-related dermatologic AEs, clinical biomarkers, can predict the efficacy of TACE-S in future randomized controlled trials.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Colorectal Disease
VL  - 12
IS  - s3
SN  - 9780470193402
UR  - https://doi.org/10.1111/j.1463-1318.2010.02367.x
DO  - doi:10.1111/j.1463-1318.2010.02367.x
SP  - 28
EP  - 52
PY  - 2010
ER  - 

TY  - JOUR
TI  - ASBMR 2010 Annual Meeting MO0001–MO0484
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 25
IS  - S1
SN  - 9780470193402
UR  - https://doi.org/10.1002/jbmr.5650251305
DO  - doi:10.1002/jbmr.5650251305
SP  - S363
EP  - S502
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Sessions (PS)
JO  - European Journal of Biochemistry
VL  - 270
IS  - s1
SN  - 9780470193402
UR  - https://doi.org/10.1046/j.1432-1033.270.s1.8.x
DO  - doi:10.1046/j.1432-1033.270.s1.8.x
SP  - 32
EP  - 235
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Haemophilia
JA  - Haemophilia
VL  - 24
IS  - S5
SN  - 9780470193402
UR  - https://doi.org/10.1111/hae.13478
DO  - doi:10.1111/hae.13478
SP  - 3
EP  - 196
PY  - 2018
ER  - 

TY  - JOUR
TI  - UK STROKE FORUM 2011 ABSTRACTS, GLASGOW, 29 NOVEMBER 2011–1 DECEMBER 2011
JO  - International Journal of Stroke
VL  - 6
IS  - s2
SN  - 9780470193402
UR  - https://doi.org/10.1111/j.1747-4949.2011.00684.x
DO  - doi:10.1111/j.1747-4949.2011.00684.x
SP  - 1
EP  - 65
PY  - 2011
ER  - 

TY  - JOUR
TI  - ASBMR 30th Annual Meeting SA001–SA572
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 23
IS  - S1
SN  - 9780470193402
UR  - https://doi.org/10.1002/jbmr.5650231304
DO  - doi:10.1002/jbmr.5650231304
SP  - S136
EP  - S243
PY  - 2008
ER  - 

TY  - JOUR
TI  - The International Liver Transplantation Society: 16th Annual International Congress
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 16
IS  - S1
SN  - 9780470193402
UR  - https://doi.org/10.1002/lt.22086
DO  - doi:10.1002/lt.22086
SP  - S1
EP  - S284
PY  - 2010
ER  - 

TY  - JOUR
TI  - American Society for Laser Medicine and Surgery 30th Annual Conference Phoenix, Arizona, April 16-April 18, 2010 Abstracts
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 42
IS  - S22
SN  - 9780470193402
UR  - https://doi.org/10.1002/lsm.20916
DO  - doi:10.1002/lsm.20916
SP  - 1
EP  - 125
PY  - 2010
ER  - 

TY  - JOUR
TI  - 2005 Meeting of the Peripheral Nerve Society  July 9–13, 2005  Tuscany, Italy
JO  - Journal of the Peripheral Nervous System
VL  - 10
IS  - s1
SN  - 9780470193402
UR  - https://doi.org/10.1111/j.1085-9489.2005.abstract.x
DO  - doi:10.1111/j.1085-9489.2005.abstract.x
SP  - 1
EP  - 108
PY  - 2005
ER  - 

TY  - JOUR
AU  - Fang, Y. L.
AU  - Chen, X. G.
AU  - W. T., Godbey
TI  - Gene delivery in tissue engineering and regenerative medicine
JO  - Journal of Biomedical Materials Research Part B: Applied Biomaterials
JA  - J. Biomed. Mater. Res.
VL  - 103
IS  - 8
SN  - 9780470193402
UR  - https://doi.org/10.1002/jbm.b.33354
DO  - doi:10.1002/jbm.b.33354
SP  - 1679
EP  - 1699
KW  - gene delivery
KW  - stem cell
KW  - enhanced multipotent
KW  - tissue engineering
KW  - regenerative medicine
PY  - 2015
AB  - Abstract As a promising strategy to aid or replace tissue/organ transplantation, gene delivery has been used for regenerative medicine applications to create or restore normal function at the cell and tissue levels. Gene delivery has been successfully performed ex vivo and in vivo in these applications. Excellent proliferation capabilities and differentiation potentials render certain cells as excellent candidates for ex vivo gene delivery for regenerative medicine applications, which is why multipotent and pluripotent cells have been intensely studied in this vein. In this review, gene delivery is discussed in detail, along with its applications to tissue engineering and regenerative medicine. A definition of a stem cell is compared to a definition of a stem property, and both provide the foundation for an in-depth look at gene delivery investigations from a germ lineage angle. ? 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1679?1699, 2015.
ER  - 

TY  - JOUR
TI  - ACR/ARHP scientific abstracts
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 42
IS  - S9
SN  - 9780470193402
UR  - https://doi.org/10.1002/art.1780422107
DO  - doi:10.1002/art.1780422107
SP  - S71
EP  - S407
PY  - 1999
ER  - 

TY  - JOUR
TI  - E-Posters
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 122
IS  - S1
SN  - 9780470193402
UR  - https://doi.org/10.1111/1471-0528.13370
DO  - doi:10.1111/1471-0528.13370
SP  - 157
EP  - 234
PY  - 2015
ER  - 

TY  - JOUR
TI  - ASBMR 2010 Annual Meeting SA0001–SA0485
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 25
IS  - S1
SN  - 9780470193402
UR  - https://doi.org/10.1002/jbmr.5650251303
DO  - doi:10.1002/jbmr.5650251303
SP  - S136
EP  - S224
PY  - 2010
ER  - 

TY  - JOUR
TI  - POSTERS
JO  - Journal of Anatomy
VL  - 212
IS  - 1
SN  - 9780470193402
UR  - https://doi.org/10.1111/j.1469-7580.2007.831_2.x
DO  - doi:10.1111/j.1469-7580.2007.831_2.x
SP  - 80
EP  - 96
PY  - 2008
ER  - 
